GSK-4716
GSK4716 is a small molecule agonist of the ERRβ and ERRγ receptors with an IC50 of 2 μM, demonstrating potency comparable to endogenous protein ligands. This compound is a valuable research tool for investigating ERR-mediated transcriptional regulation in metabolic, neurodegenerative, and cancer-related studies using both cellular and animal models.
Product Specifications
CAS Number
101574-65-6
Product Name Alternative
Inhibit, Inhibitor, GSK 4716, GSK4716, GSK-4716, Estrogen Receptor/ERR, EstrogenReceptor, Estrogen Receptor, ERR, ERRβ/γ
Field of Research
Metabolism Research
Purity
98.00% (May vary between batches)
Solubility
DMSO:100 mg/mL (354.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (14.17 mM)
Smiles
CC (C) c1ccc (\C=N\NC (=O) c2ccc (O) cc2) cc1
Molecular Formula
C17H18N2O2
Molecular Weight
282.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ERI1, NT (ERI1, 3'EXO, THEX1, 3'-5' exoribonuclease 1, 3'-5' exonuclease ERI1, Eri-1 homolog, Histone mRNA 3'-end-specific exoribonuclease, Histone mRNA 3'-exonuclease 1, Protein 3'hExo) (AP)
ERI1, NT (ERI1, 3'EXO, THEX1, 3'-5' exoribonuclease 1, 3'-5' exonuclease ERI1, Eri-1 homolog, Histone mRNA 3'-end-specific exoribonuclease, Histone mRNA 3'-exonuclease 1, Protein 3'hExo) (AP)
Phospho-RGS19 (Ser24) Polyclonal Antibody, PE-Cy5 Conjugated
